Area of research
Cancer Research · Hepatology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer-related molecular mechanisms research, Hepatocellular Carcinoma Treatment and Prognosis, and Lung Cancer Treatments and Mutations.
Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell‐death mediator receptor‐interacting protein kinase 1
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype
Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression
P0282 : The long non coding RNA UC.158 modulates growth of Wnt/β;-catenin driven hepatocellular carcinoma (HCC)
Human and Mouse <i>VEGFA</i> -Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients